Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity
NotiVIH
1 other identifier
interventional
400
0 countries
N/A
Brief Summary
The context of HIV has changed dramatically this last two decades with the availability of highly active and well tolerated antiretroviral therapies, and the extension of prevention methods to include treatment as prevention of onward transmissions. It is time to test and treat as many HIV infected people as possible. HIV testing that target people known to have been exposed to HIV is an interesting option to explore to curb the spread of the epidemic. Notifying HIV exposed sexual partner for them to get an HIV test and treatment contribute to reduce HIV transmissions. The partner notification (PN) gives the opportunity to HIV positive partners to access to care and negative partners, access to prevention services. Several tools have been developed worldwide, in particular in the United Kingdom and the US, to help HIV or index patients to notify their sexual partner or needle-sharing people. This approach is new in France and PN intervention has to be assessed. The present study aimed to assess the effectiveness of a digital PN tool or a counselling interview to help men having sex with men (MSM) newly diagnosed for HIV to notify their exposed partners. The study also aimed to evaluate the acceptability of these PN intervention in index patients and their notified partners in the French context. To meet the objectives, an interventional study was developed in index patients (described above) coupled with :
- an observational study in notified partners to assess their PN acceptability and their HIV testing uptake after being notified
- a qualitative study in a sample of index patients and notified partner to assess more in depth their PN acceptability. Expected results and perspectives Feasible and effective, assisted PN services may complete HIV testing offer (and by extension sexually transmitted infections screening) as well as the prevention offer Pre-Exposure Prophylaxis (PrEP) for MSM. The study will provide information enabling the best practice guides. In a next step, PN interventions adapted to other key populations will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv-infections
Started Jun 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2024
CompletedFirst Posted
Study publicly available on registry
May 17, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
May 23, 2024
May 1, 2024
2 years
May 14, 2024
May 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percentage of partners notified one month after the intervention, among the number of exposed partners stated by index patients
An emailed invitation to complete an online self-administered questionnaire will be send to index patients to carry out an assessment of the notification process (number of partners exposed, contacted, notified, etc). Up to 3 reminders will be sent if no response.
One month after the intervention
Secondary Outcomes (2)
Percentage of acceptability of partner notification by index patients
One month after the intervention
Percentage of adverse events of partner notification reported by index patients
One month after the intervention
Study Arms (2)
Digital notification tool
NO INTERVENTIONA partner notification digital tool allowing the sending of anonymous or personalised standardised text messages to partners and an information leaflet are provided to index patients
Digital notification tool and counseling
EXPERIMENTALIn addition to the provision of the partner notification digital tool and the leaflet, a partner notification approach assisted by a trained counsellor during a specific counselling interview is offered to index patient.
Interventions
One (or more if needed) interview with a partner notification trained counsellor is offered to index patients. During the interview, the counsellor gives information on partner notification, helps the index patients to remember their partners, to assess their HIV/sexually transmitted infection exposure and explains options to notify them. During the interview, the index patient can choose to entrust the notification of some of their partners to the counsellor. However, according to French law, provider referral is permitted only when it is anonymous. Therefore, this option is reserved to partners with a lot of partners in order to limit the risk of identifying the index patient
Eligibility Criteria
You may qualify if:
- men
- aged ≥18
- having sex with ≥2 men in the last 12 months
You may not qualify if:
- Persons who do not provide an email address, needed to receive the study questionnaires
- Persons who do not speak or read French
- Persons subject to a legal protection measure (guardianship, safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jade Ghosn, MD PhD
AP-HP Hôpital Bichat Claude-Bernard, Paris, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2024
First Posted
May 17, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
May 23, 2024
Record last verified: 2024-05